how safe is hers semaglutide Hims? Hers? It's Novo Nordisk's Market Now Wegovy maker ends partnership with

Clinical trial data shows weight regain typically begins within 6 to 12 months of complete discontinuation, supporting ongoing maintenance rather than stopping entirely

From celebrity endorsements to social media buzz, these medications have sparked excitement, debate, and many questions

The trial protocol was designed to test the upper limits, not prescribe a one-size-fits-all approach

Orandi At 5 years of follow-up, significantly fewer GLP-1 drug users (7.5%) than nonusers (12.2%) experienced death-censored graft loss, for a 49% lower risk for graft loss with GLP-1 drug use when adjusted for insulin use (adjusted subhazard ratio [aSHR] = 0.51

Preclinical data suggests that triple agonism may shift the ratio of fat-to-lean mass loss in a more favorable direction

The appetite changes kicked in around week two and eating became almost an afterthought